EFFECT OF PRAZIQUANTEL TREATMENT ON BRAIN AND KIDNEY ATPASE ACTIVITIES IN HEALTHY AND SCHISTOSOMA MANSONI-INFECTED MICE

被引:0
|
作者
SHAHEEN, AA [1 ]
EBEID, A [1 ]
机构
[1] THEODOR BILHARZ RES INST,CAIRO,EGYPT
来源
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1992年 / 42-2卷 / 12期
关键词
ANTHELMINTICS; ATPASE; BRAIN AND KIDNEY; CAS; 55268-74-1; EMBAY; 8440; PRAZIQUANTEL; PHARMACOLOGY; SCHISTOSOMA MANSONI INFECTION;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Na+-K+-dependent ouabain-sensitive ATPase and Mg2+-ATPase activities have been assayed in brain and kidney of healthy and Schistosoma mansoni-infected mice before and after praziquantel (EMBAY 8440, CAS 55268-74-1) treatment. Schistosoma mansoni infection caused a moderate decrease of brain Na + -K+ -ATPase activity with a marked inhibition of its Mg-stimulated ATPase. Meanwhile, a marked inhibition in both renal ATPase activities was observed in infected mice. Treatment of the infected mice with praziquantel (2 x 500 mg/kg b. wt.) reversed the inhibitory effect of infection on brain and kidney ATPase, so that the activity of both renal ATPase and that of brain Mg-ATPase were nearly corrected while the activity of brain Na + -K+ -ATPase was increased to an extent greater than normal values. However, treatment of normal mice with praziquantel did not affect any of the measured parameters. Possible explanations of these findings are given.
引用
收藏
页码:1504 / 1506
页数:3
相关论文
共 50 条
  • [1] Ultrastructural changes of kidney in Schistosoma mansoni-infected mice
    Eid, Refaat A.
    Al-Shraim, Mubarak
    El-Sayed, Fahmy
    Radad, Khaled
    ULTRASTRUCTURAL PATHOLOGY, 2017, 41 (05) : 320 - 326
  • [2] Resolution of systemic complications in Schistosoma mansoni-infected mice by concomitant treatment with praziquantel and Schisandrin B
    Lam, Ho Yin Pekkle
    Cheng, Po-Ching
    Peng, Shih-Yi
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2022, 52 (05) : 275 - 284
  • [3] Effect of praziquantel treatment on the activities of some liver microsomal enzymes in mice infected with Schistosoma mansoni
    Ezzat, AR
    el-Din, SHS
    Ebeid, FA
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2001, 51 (04): : 325 - 331
  • [4] Factors controlling the effect of praziquantel on liver fibrosis in Schistosoma mansoni-infected patients
    Rahoud, Siddig A.
    Mergani, Adil
    Khamis, Ammar H.
    Saeed, Osman K.
    Mohamed-Ali, Qurashi
    Dessein, Alain J.
    Elwali, Nasr Eldin M. A.
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2010, 58 (01): : 106 - 112
  • [5] Bioavailability and in vivo efficacy of a praziquantel–polyvinylpyrrolidone solid dispersion in Schistosoma mansoni-infected mice
    Naglaa El-Lakkany
    Sayed Hassan Seif el-Din
    Lamia Heikal
    European Journal of Drug Metabolism and Pharmacokinetics, 2012, 37 : 289 - 299
  • [6] Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice
    Panic, Gordana
    Ruf, Marie-Therese
    Keiser, Jennifer
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (12)
  • [7] Bioavailability and in vivo efficacy of a praziquantel-polyvinylpyrrolidone solid dispersion in Schistosoma mansoni-infected mice
    El-Lakkany, Naglaa
    Seif el-Din, Sayed Hassan
    Heikal, Lamia
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2012, 37 (04) : 289 - 299
  • [8] Therapeutic effect of praziquantel enantiomers in mice infected with Schistosoma mansoni
    Xiao, S
    Chollet, J
    Booth, M
    Weiss, NA
    Tanner, M
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1999, 93 (03) : 324 - 325
  • [9] EFFECT OF PRAZIQUANTEL ON PLATELET LEVELS IN MICE INFECTED WITH SCHISTOSOMA-MANSONI
    WAMBAYI, EJ
    KASILI, EG
    KIMANI, G
    WARUINGE, D
    EAST AFRICAN MEDICAL JOURNAL, 1993, 70 (10) : 665 - 666
  • [10] The Significance of Vasoactive Intestinal Peptide in the Treatment of Schistosoma mansoni-Infected Diabetic Mice
    Ahmed, Osama M.
    Allam, Gamal
    ASIAN JOURNAL OF ANIMAL AND VETERINARY ADVANCES, 2009, 4 (04): : 172 - 190